Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -499,144 | -335,731 | -140,956 | 515,837 | 617,440 |
| Depreciation Amortization | 4,915 | -1,980 | -3,727 | -2,160 | 3,515 |
| Income taxes - deferred | N/A | N/A | N/A | -15,186 | N/A |
| Accounts receivable | 3,041 | 3,041 | 2,093 | 770,038 | 491,872 |
| Accounts payable and accrued liabilities | -1,895 | 5,630 | 6,564 | 797 | -2,003 |
| Other Working Capital | -271,843 | -242,150 | 10,725 | 665,367 | 535,549 |
| Other Operating Activity | 94,068 | 56,161 | -481 | -271,440 | -18,246 |
| Operating Cash Flow | $-670,858 | $-515,029 | $-125,782 | $1,663,253 | $1,628,127 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 289,478 | 344,718 | 104,946 | -1,125,455 | -984,916 |
| PPE Investments | -20,038 | -16,324 | -6,867 | -68,006 | -55,410 |
| Investing Cash Flow | $269,440 | $328,394 | $98,079 | $-1,193,461 | $-1,040,326 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -183 |
| Debt Repayment | -200 | -134 | -66 | -260 | N/A |
| Common Stock Issued | 6,000 | 5,657 | 2,410 | 36,218 | 34,130 |
| Other Financing Activity | 0 | 0 | 0 | -1,197 | -1,197 |
| Financing Cash Flow | $5,800 | $5,523 | $2,344 | $34,761 | $32,750 |
| Beginning Cash Position | 867,968 | 867,968 | 867,968 | 363,415 | 363,415 |
| End Cash Position | 472,350 | 686,856 | 842,609 | 867,968 | 983,966 |
| Net Cash Flow | $-395,618 | $-181,112 | $-25,359 | $504,553 | $620,551 |
| Free Cash Flow | |||||
| Operating Cash Flow | -670,858 | -515,029 | -125,782 | 1,663,253 | 1,628,127 |
| Capital Expenditure | -20,038 | -16,324 | -6,867 | -68,006 | -55,432 |
| Free Cash Flow | -690,896 | -531,353 | -132,649 | 1,595,247 | 1,572,695 |